Skip to main content
. 2015 Feb 11;59(3):1770–1775. doi: 10.1128/AAC.03522-14

TABLE 2.

Pfmspdbl1 SNPs significantly associated with drug responses to chloroquine and lumefantrine

Codon(s) SNP(s) Nucleotide(s) (amino acid[s])a Chloroquine
Lumefantrine
n (%) Median IC50 (nM) 95% CI P value n (%) Median IC50 (nM) 95% CI P value
351, 354 1051, 1060 G, A (DK) 12 (32) 14.7 12.6–31.5 12 (32) 206 52.4–344.9
A, G (NE) 25 (68) 86.2 58.1–104.3 0.0013b 25 (68) 80.8 66.3–97.8 0.04b
358, 359 1072, 1074, 1075, 1076 A, C, C, A (IQ) 14 (38) 23.8 14.0–93.8 14 (38) 136.8 66.2–334.8
G, A, A, G (VR) 23 (62) 85.2 55.9–99.7 0.05b 23 (62) 84.6 53.2–102.0 0.04b
361 1081 T (F) 15 (41) 30.7 14.4–95.7 15 (41) 111.6 68.9–330.0
A (I) 22 (59) 85.7 56.4–102.3 0.08 22 (59) 82.7 48.5–98.2 0.03b
365 1093 G (D) 13 (36) 16.8 13.3–102.1 13 (36) 104.4 62.7–340.9
A (N) 23 (64) 85.2 55.9–99.7 0.07 23 (64) 84.6 53.2–102.0 0.05b
380 1139 A (E) 14 (37) 24.2 14.0–98.9 14 (37) 108 66.2–334.8
G (G) 24 (63) 84.1 48.2–96.1 0.12 24 (63) 87.7 60.2–110.5 0.06
380, 398, 416 1140, 1194, 1247 A, C, T (EGI) 14 (38) 24.2 14.0–98.9 14 (38) 108 66.2–334.8
T, T, G (GGR) 23 (62) 85.2 55.9–99.7 0.11 23 (62) 84.6 53.2–102.0 0.045b
420 1259 A (K) 15 (39) 31.6 14.4–95.7 15 (39.5) 111.6 68.9–330.0
T (I) 23 (61) 85.2 55.9–99.7 0.09 23 (60.5) 84.6 53.2–102.0 0.035b
444 1332 A (K) 26 (74) 84.1 31.1–99.7 26 (74) 104.3 77.7–206.6
T (N) 9 (26) 56.4 12.8–103.6 0.5 9 (26) 48.6 36.9–93.8 0.03b
631 1891 A (K) 24 (67) 30.5 14.9–82.5 24 (67) 100.7 76.9–160.3
G (E) 12 (33) 103.3 59.2–114.9 0.0025b 12 (33) 61.8 36.9–270.6 0.17
669 2007 T (N) 19 (58) 30.7 15.5–82.3 19 (58) 97.6 73.3–138.1
C (N) 14 (42) 106.4 78.6–123.8 0.0015b 14 (42) 58.1 38.0–240.1 0.19
a

The bold letters highlight the 3D7 reference alleles.

b

Significant result (P ≤ 0.05).